Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo D Kim

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemiaPhilipp le Coutre, Michaela Schwarz, Theo D Kim
Current Hematologic Malignancy Reports|April 29, 2010
Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemiaTheis H Terwey, Theo D Kim, Renate Arnold
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
NilotinibMartin Gresse, Theo D Kim, Philipp le Coutre
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
NilotinibBenjamin N Ostendorf, Philipp le Coutre, Theo D Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transportDoreen Braun, Theo D Kim, Philipp le Coutre, et al.
Haematologica|December 18, 2009
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Seval Türkmen, Michaela Schwarz, et al.
Leukemia & Lymphoma|December 8, 2010
Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinibTheo D Kim, Michaela Schwarz, Karl-Anton Kreuzer, et al.
Haematologica|January 25, 2012
Clinical cardiac safety profile of nilotinibTheo D Kim, Philipp le Coutre, Michaela Schwarz, et al.
Thyroid : Official Journal of the American Thyroid Association|October 9, 2010
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Michaela Schwarz, Hendrik Nogai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradicationThomas Wündisch, Christian Thiede, Andrea Morgner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemiaPhilipp le Coutre, Michaela Schwarz, Theo D Kim
Current Hematologic Malignancy Reports|April 29, 2010
Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemiaTheis H Terwey, Theo D Kim, Renate Arnold
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
NilotinibMartin Gresse, Theo D Kim, Philipp le Coutre
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
NilotinibBenjamin N Ostendorf, Philipp le Coutre, Theo D Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transportDoreen Braun, Theo D Kim, Philipp le Coutre, et al.
Haematologica|December 18, 2009
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Seval Türkmen, Michaela Schwarz, et al.
Leukemia & Lymphoma|December 8, 2010
Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinibTheo D Kim, Michaela Schwarz, Karl-Anton Kreuzer, et al.
Haematologica|January 25, 2012
Clinical cardiac safety profile of nilotinibTheo D Kim, Philipp le Coutre, Michaela Schwarz, et al.
Thyroid : Official Journal of the American Thyroid Association|October 9, 2010
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Michaela Schwarz, Hendrik Nogai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradicationThomas Wündisch, Christian Thiede, Andrea Morgner, et al.
Pageof 2